home / stock / artl / artl news

ARTL News and Press, Artelo Biosciences Inc. From 11/08/22

Stock Information
Company Name: Artelo Biosciences Inc.
Stock Symbol: ARTL
Market: OTC
Website: artelobio.com
Menu
ARTL ARTL Quote ARTL Short ARTL News ARTL Articles ARTL Message Board
Get ARTL Alerts

News, Short Squeeze, Breakout and More Instantly...
ARTL - Artelo Biosciences GAAP EPS of -$0.82 beats by $0.09

Artelo Biosciences press release ( NASDAQ: ARTL ): Q3 GAAP EPS of -$0.82 beats by $0.09 . As of September 30, 2022, the Company had approximately $19.5 million in cash and investments, compared to $25.6 million as of December 31, 2021. Operating expenses for ...
ARTL - Artelo Biosciences Reports Third Quarter 2022 Financial Results and Provides Business Update

Enrollment of Phase 2a CAReS Study Expected to Commence Near Year-End $19.5 Million in Cash and Investments as of September 30, 2022 SOLANA BEACH, Calif., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) , a clinical-stage pharmaceutical co...

ARTL - Artelo Biosciences to Present at The LD Micro Main Event XV

Solana Beach, California--(Newsfile Corp. - October 18, 2022) - Artelo Biosciences, Inc.  (NASDAQ: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and neurological conditions, today a...

ARTL - Artelo Biosciences to Present at the 2022 Ladenburg Thalmann Healthcare Conference on September 29th

SOLANA BEACH, Calif., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) , a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and neurological conditions, ...
ARTL - Artelo Biosciences to Present at the H.C. Wainwright 24th Annual Global Investment Conference

SOLANA BEACH, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) , a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and neurological conditions, ...

ARTL - BWV and BMEA among mid-day movers

Gainers: Blue Water Vaccines ( BWV ) +108% . Hill International ( HIL ) +61% . Eargo ( EAR ) +58% . JE Cleantech Holdings ( JCSE ) +44% . Cassava Sciences ( SAVA ) +30% . Laird Superfood ( LSF ) +19% . LexinFintec...

ARTL - Blue Water, Eargo top healthcare gainers; Blueprint, Artelo lead losers' pack

Gainers: Blue Water Vaccines ( BWV ) +57% . Eargo ( EAR ) +49% . Cassava Sciences ( SAVA ) +29% . MiNK Therapeutics ( INKT ) +24% . Cogent Biosciences ( COGT ) +16% . Losers: Blueprint Medicines ( BPMC ) -22% ....
ARTL - Sanofi, Sibanye Stillwater, Option Care Health among premarket losers' pack

Blueprint Medicines ( BPMC ) -13% on reports to seek label expansion for systemic mastocytosis therapy after trial win . Artelo Biosciences ( ARTL ) -13% . Krispy Kreme ( DNUT ) -12% on Q2 earnings release . Forza X1 ( FRZA ) -12% . ...

ARTL - FUBO, CASI and KIRK among mid-day movers

Gainers: GreenBox ( GBOX ) +107% . Bed Bath & Beyond ( BBBY ) +55% . Artelo Biosciences ( ARTL ) +49% . Kirkland's ( KIRK ) +44% . SkyWater Technology ( SKYT ) +37% . fuboTV ( FUBO ) +33% . Ventyx Biosciences ...

ARTL - Artelo, Ventyx top healthcare gainers; Albireo, Sema4 lead losers' pack

Gainers: Artelo Biosciences ( ARTL ) +31% . Ventyx Biosciences ( VTYX ) +23% . Eargo ( EAR ) +19% . Fulcrum Therapeutics ( FULC ) +18% . Genprex ( GNPX ) +17% . Losers: Albireo Pharma ( ALBO ) -25% . Sema4...
Previous 10 Next 10